Catherine Datto
Overview
Explore the profile of Catherine Datto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
522
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ho C, OQuinn S, Bailey J, Meyers O, Slagle A, Dellon E, et al.
Orphanet J Rare Dis
. 2021 Nov;
16(1):495.
PMID: 34819137
Background: A patient reported outcome (PRO) instrument with evidence of validity and reliability for assessing symptoms of eosinophilic gastritis (EG) and eosinophilic gastroenteritis (EGE) is needed to measure treatment benefit...
2.
Lamerato L, Wittbrodt E, Kaur M, Datto C, Singla S
JGH Open
. 2020 Jun;
4(3):490-496.
PMID: 32514459
Aims: Constipation associated with opioid therapy for chronic pain may negatively impact colonoscopy success. This retrospective, observational study using administrative data and electronic medical records evaluated the impact of opioid...
3.
Brenner D, Hu Y, Datto C, Creanga D, Camilleri M
Am J Gastroenterol
. 2019 Oct;
114(10):1695.
PMID: 31567191
No abstract available.
4.
Brenner D, Hu Y, Datto C, Creanga D, Camilleri M
Am J Gastroenterol
. 2019 May;
114(6):954-963.
PMID: 31058652
Objectives: To determine patient preference for treating opioid-induced constipation (OIC) using naloxegol or polyethylene glycol (PEG) 3350 in patients receiving opioids for noncancer pain. Methods: This crossover study included two...
5.
Vallerand A, Hendry S, Baldys E, Hu Y, Datto C
Pain Med
. 2018 Aug;
20(5):889-896.
PMID: 30125008
Objective: This analysis of patient-health care provider discussions of opioid-induced constipation (OIC) evaluated the dynamics of interactions, identified communication gaps, and assessed the functional burden of opioid-induced constipation on patients'...
6.
Fine P, Chen Y, Wittbrodt E, Datto C
Support Care Cancer
. 2018 Jul;
27(2):687-696.
PMID: 30056531
Purpose: Opioid therapy is often associated with adverse effects, including opioid-induced constipation (OIC), in patients receiving opioids for cancer pain. This retrospective observational cohort study evaluated healthcare utilization and costs...
7.
Nalamachu S, Gudin J, Datto C, Coyne K, Poon J, Hu Y
J Opioid Manag
. 2018 Jul;
14(3):211-221.
PMID: 30044486
Objective: Efficacy and safety of naloxegol, a peripherally acting µ-opioid receptor antagonist that significantly reduces opioid-induced constipation (OIC), were assessed for patient subgroups defined post hoc by baseline maintenance opioid...
8.
Wittbrodt E, Gan T, Datto C, McLeskey C, Sinha M
J Pain Res
. 2018 Jun;
11:1017-1025.
PMID: 29881304
Purpose: Constipation is a well-known complication of surgery that can be exacerbated by opioid analgesics. This study evaluated resource utilization and costs associated with opioid-induced constipation (OIC). Patients And Methods:...
9.
Gupta A, Coyne K, Datto C, Venuti C
Pain Med
. 2018 Feb;
19(12):2459-2468.
PMID: 29420795
Objective: The purpose of this analysis was to evaluate the experience of opioid-induced constipation in younger patients and identify differences in the experience of opioid-induced constipation and its symptoms between...
10.
Olufade T, Kong A, Princic N, Juneau P, Kulkarni R, Zhang K, et al.
Am Health Drug Benefits
. 2017 Jun;
10(2):79-86.
PMID: 28626504
Background: Constipation is a common adverse effect of opioid use and has been associated with increased healthcare utilization and costs among patients receiving opioids for pain management. Objective: To compare...